 |
|
|
| |
Week-48 Outcomes From the BRAAVE 2020 Study: a Randomized Switch to B/F/TAF in African-American Adults With HIV
|
| |
| |
IDWeek 2020 Oct 21-25 vurtual
Reported by Jules Levin
Debbie Hagins,1 Princy Kumar,2 Michael Saag,3 Anson K. Wurapa,4 Indira Brar,5 Daniel Berger,6 Olayemi Osiyemi,7 Corrilynn O. Hileman,8 Moti Ramgopal,9 Cheryl McDonald,10 Christiana Blair,11 Kristen Andreatta,11 Sean E. Collins,11 Diana Brainard,11 Hal Martin,11 on behalf of the BRAAVE2020 Investigators
1The Chatham CARE Center, Chatham County Health Dept, Savannah, GA; 2MedStar Health, Washington, DC; 3The University of Alabama at Birmingham; 4Infectious Disease Specialists of Atlanta, P.C., Decatur, GA; 5Henry Ford Hospital, Detroit, MI; 6Northstar Healthcare, Chicago, IL; 7Triple O Research Institute P A., West Palm Beach, FL; 8Case Western Reserve University, Cleveland, OH; 9Midway Research Center, Fort Pierce, FL; 10Texas Centers for Infectious Disease Associates, Fort Worth, TX; 11Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
